Doxorubicin Market Revenue to Cross $1,983.40 million by 2028 to Rise at a Stellar CAGR of 6.1% by 2028 | Exclusive Research by The Insight Partners
July 12, 2022 10:54 ET
|
The Insight Partners
New York, July 12, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on "Doxorubicin Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Drug Formulation,...
Global Doxorubicin Market Trajectory & Analytics Report 2022-2026: Rising Incidence of Cancers & Development of Technologically Advanced Systems for Drug Delivery Driving Growth
May 25, 2022 06:58 ET
|
Research and Markets
Dublin, May 25, 2022 (GLOBE NEWSWIRE) -- The "Doxorubicin - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Doxorubicin Market to Reach...
Rising Incidence of Cancer to Drive Doxorubicin Market at CAGR of 5.3% through 2026: Fact.MR Research
May 04, 2022 19:00 ET
|
FACT.MR
United States, Rockville MD, May 04, 2022 (GLOBE NEWSWIRE) -- According to a recently published Fact.MR report, the global Doxorubicin Market is projected to grow at a compound annual rate (CAGR) of...
Global Ovarian Cancer Drugs Market to 2031 - Featuring AstraZeneca, Roche and Tesaro Among Others
March 29, 2022 05:23 ET
|
Research and Markets
Dublin, March 29, 2022 (GLOBE NEWSWIRE) -- The "Ovarian Cancer Drugs Global Market Report 2022, Tumor Type, Distribution Channel, Drug Type" report has been added to ResearchAndMarkets.com's...
Global Doxorubicin Market Research Report (2021 to 2027) - by Drug Formulation, Application, Distribution Channel and Region
February 02, 2022 08:53 ET
|
Research and Markets
Dublin, Feb. 02, 2022 (GLOBE NEWSWIRE) -- The "Doxorubicin Market Research Report by Drug Formulation, by Application, by Distribution Channel, by Region - Global Forecast to 2027 - Cumulative...
Global Follicular Lymphoma Market and Epidemiology Landscape Report 2021-2030 - Discover the Drivers, Barriers, and Unmet Medical Needs to Curate the Best Opportunities
December 17, 2021 07:13 ET
|
Research and Markets
Dublin, Dec. 17, 2021 (GLOBE NEWSWIRE) -- The "Follicular Lymphoma Market Insights, Epidemiology, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. This report...
Insights on the Liposomal Doxorubicin Global Market to 2026 - by Product, Application and Region
December 06, 2021 06:08 ET
|
Research and Markets
Dublin, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The "Liposomal Doxorubicin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
Plus Therapeutics Reports Q2 2019 Financial and Business Results
August 15, 2019 19:21 ET
|
Plus Therapeutics, Inc.
AUSTIN, Texas, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) today announced Q2 2019 financial results and provided updates on corporate activities. Q2...
Celsion Corporation Announces Issuance of New Patent for ThermoDox®
April 17, 2019 08:00 ET
|
Celsion CORP
Represents a Significant Advance for Celsion’s Life Cycle Management Program for ThermoDox® Establishing Bioequivalence Will Extend Market Exclusivity to 2033 LAWRENCEVILLE, N.J,...
INFORM GENOMICS and TESARO Enter Into Collaboration Agreement
October 15, 2013 07:00 ET
|
Inform Genomics
Boston, MA, Oct. 15, 2013 (GLOBE NEWSWIRE) -- Inform
Genomics, Inc., a private company focused on developing novel
platforms of genomic-based, personalized medicine products for
cancer supportive...